Journal
BIOMARKERS IN MEDICINE
Volume 9, Issue 12, Pages 1343-1351Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/bmm.15.100
Keywords
biomarkers; cirrhosis; hepatocellular carcinoma; infection; liver; surveillance
Categories
Ask authors/readers for more resources
The early detection of bacterial infections and hepatocellular carcinoma (HCC) could ameliorate the prognosis of cirrhosis. C-reactive protein and procalcitonin are under investigation in the setting of cirrhosis as markers of sepsis. In the attempt to discriminate bacterial infection from systemic inflammation, the role of novel biomarkers such as lypopolysaccharide binding-protein, mid-regional fragment of proadrenomedullin and delta neutrophil index are currently in development. Concerning HCC, many studies attempted to evaluate biomarkers in the hope of ameliorating the accuracy of the surveillance based on ultrasound. The use of alpha-fetoprotein (AFP) has been extensively investigated, as well as other biomarkers expressed in the serum of HCC patients like lens culinaris agglutinin-reactive fraction of AFP, des-gamma-carboxy prothrombin, glypican-3, alpha-l-fucosidase and their combined use.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available